Register Login

Summit Plc (SMMT)

  • Event
  • June 01, 2022, 20:31 UTC

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Delay in difference Trials for multiple business unit CFO roles Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 3:17 a.m.

    📋 Summit Therapeutics Inc. (SMMT) - Clinical Trial Update

    Filing Date: 2022-06-01

    Accepted: 2022-06-01 16:31:36

    Event Type: Clinical Trial Update

    Event Details:

    Summit Plc (SMMT) Announces Clinical Trial Update Summit Plc (SMMT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: difference, serving
    • Diseases/Conditions: multiple business unit CFO roles
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: the Institute of Chartered Accountants

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Summit Plc
    • CIK: 0001599298
    • Ticker Symbol: SMMT
    • Period End Date: 2022-06-01
    • Document Type: 8-K

Search

News categories